Q1 2026 Elevance Health Inc Earnings Call Transcript
Key Points
- Elevance Health Inc (ELV) exceeded first-quarter expectations with strong underlying business performance and favorable claims experience.
- The company raised its full-year adjusted diluted earnings per share guidance to at least $26.75, reflecting confidence in its business trajectory.
- Elevance Health Inc (ELV) is embedding and scaling AI across clinical, operational, and administrative workflows, leading to improved member engagement and cost management.
- The company is transforming care delivery through Carelon, achieving a 20% reduction in hospital readmissions and over 10% savings on post-acute care.
- Elevance Health Inc (ELV) reported strong demand for Carelon's capabilities, reinforcing its role as a driver of current performance and long-term growth.
- Elevance Health Inc (ELV) recorded a $935 million accrual related to historical risk adjustment data, reflecting potential exposure.
- The company faces ongoing challenges with Medicaid margins, maintaining a negative 1.75% operating margin outlook for the full year.
- Elevance Health Inc (ELV) experienced lower health plan membership, impacting Carelon's first-quarter operating gain.
- The company recorded a $129 million charge related to business optimization, reflecting ongoing actions to simplify organizational structures.
- Elevance Health Inc (ELV) is addressing rapid growth in ABA therapy through rigorous clinical oversight, indicating potential cost pressures.
Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health first-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded. I would now like to turn the conference over to the company's management. Please go ahead.
Good morning, and welcome to Elevance Health's first-quarter 2026 earnings conference call. My name is Nathan Rich, Vice President of Investor Relations. With us on the earnings call are Gail Boudreaux, President and CEO; Mark Kaye, our CFO; Felicia Norwood, our Chief Health Benefits Officer; Morgan Kendrick, President of our Commercial Health Benefits Business; and Aimee Dailey, President of our Government Health Benefits business.
Gail will open the call by highlighting our first-quarter performance and the actions we are taking to advance our strategic priorities. Mark will then discuss our financial results and revised outlook in greater detail. After our prepared remarks, the team will be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
